Mainland China

Xinhua Silk Road: Financial Street Forum annual conference to be held on Oct. 27-30 in Beijing

BEIJING, Oct. 19, 2025 /PRNewswire/ -- The annual conference of Financial Street Forum 2025 will be held onOctober 27-30 in Beijing. Over 400 delegates from more than 30 countries and regions will join the four-day conference, introduced by an official of the organizing committee of the forum at...

2025-10-20 09:35 1002

CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational clinical trial of satricabtagene autoleucel ("satri-cel", CT041)...

2025-10-20 08:15 1238

ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

SUZHOU, China, Oct. 19, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616),  an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key disease areas, today announced the first disclosure...

2025-10-20 08:10 1071

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.  (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today anno...

2025-10-20 07:00 1154

Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and conventional therapies for multiple myeloma are typically...

2025-10-19 14:00 1585

China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks

CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- According to Sichuan International Communication Center, onOctober 17 (Beijing time), the "Sichuan Ease" cultural tourism logo made its global debut simultaneously across five landmark locations worldwide, including Times Square inNew York, Westfield ...

2025-10-18 21:20 1671

Where Tech Meets Soul: CASEKOO Debuts 'Tribute to Artists' Series at West Bund Museum Art Store

LOS ANGELES, Oct. 17, 2025 /PRNewswire/ -- CASEKOO, the innovative tech accessories brand, announced its debut at the West Bund Museum Art Store with the launch of the "Tribute to Artists" series inShanghai, China. This exclusive collection marks a strategic entry into the art world, positioning ...

2025-10-18 05:00 1793

PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (Nasdaq: PT) ("PINTEC" or the "Company"), a leading technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that its subsidiary ZIITECH PTY LTD ("ZIITEC...

2025-10-18 04:05 3246

Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated a favorable safety profile, with manageable hematologic and Gastrointestinal toxicities Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and ...

2025-10-17 22:00 3519

Wired Magazine Founding Editor Kevin Kelly Visits Rokid Headquarters, Exploring the Future of AR and AI

HANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Kevin Kelly, founding executive editor of Wired magazine, visitedRokid headquarters inHangzhou for a deep dialogue with Misa Zhu, Founder & CEO of Rokid.

2025-10-17 21:00 1793

Re-imagining Neo-Pragmatic Lifestyle: EPWK Launches Strategic Upgrade with "EPWK Curated Goods"

XIAMEN, China, Oct. 17, 2025 /PRNewswire/ -- "We grew weary of life's monotony, so we embarked on a journey to find 'EPWK Curated Goods.' Each selected item must pass our stringent 'Three Goods' standard: Good-looking, Good-to-use, and Good-surprise. We believe that truly excellent products can i...

2025-10-17 20:36 1438

One Heung Kong Leads the Way! New Global Benchmark for Healthy Living Announced

GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune...

2025-10-17 18:35 1345

Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

WENZHOU, China, Oct. 17, 2025 /PRNewswire/ -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer and exporter of advanced power solution products, today announced the establishment of its U.S. subsidiary, Nexora Group Inc., marking a strategic mile...

2025-10-17 18:16 2120

NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025

BEIJING, Oct. 17, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that it will hold an annual general meeting (the "AGM") of shareholders (the "Not...

2025-10-17 17:00 1378

Shanghai-London Screen Industry Forum Returns for Third Edition, Strengthening Sino-British Creative Ties and Showcasing Global Storytelling

LONDON, Oct. 17, 2025 /PRNewswire/ -- Following two successful previous gatherings, the 3rd Shanghai-London Screen Industry Forum convened at BAFTA in London today. The event brought together key players and emerging creatives from the Chinese and UK screen sectors, reinforcing its role as a vital...

2025-10-17 16:00 1100

Tomorrowland 2025: Overcoming Adversity with Unity

SHENZHEN, China, Oct. 17, 2025 /PRNewswire/ -- Tomorrowland is more than just a music festival - it's a global gathering where hundreds of thousands of "People of Tomorrow" return to Boom,Belgium each summer to celebrate electronic music, creativity, and connection. Its guiding spirit -Live Today...

2025-10-17 15:19 1655

2nd World Conference on China Studies opens in Shanghai

SHANGHAI, Oct. 17, 2025 /PRNewswire/ -- A news report from iQingdao: On October 14, the 2nd World Conference on China Studies was launched in Shanghai, gathering approximately 500 distinguished scholars and specialists from various countries. The event aims to foster greater mutual understanding ...

2025-10-17 13:43 915

Yiwu Global Digital Trade Center Opens, Setting Worldwide Digital Commerce Benchmark

YIWU, China, Oct. 17, 2025 /PRNewswire/ -- Yiwu Global Digital Trade Center, flagship project of the city's sixth-generation market, officially opened on Oct. 14. The launch completes the market's latest upgrade and signals Yiwu's shift from traditional trade to a full-scale digital-commerce ecosy...

2025-10-17 12:59 1107

Cell Publishes Breakthrough Research Results of IASO Bio's Anti-BCMA CAR-T Equecabtagene Autoleucel in Autoimmune Disease Multiple Sclerosis

SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that theCell published results fr...

2025-10-16 20:45 1380

Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025

SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson'sdisease (PD) and other neurological disorders, announced positive 6-month follow-up data from the first patient in its phase 1 clinical trial ...

2025-10-16 20:35 1283
1 ... 25262728293031 ... 821